Michael Schrader is the founding CEO of Vaxess Technologies, a Gates Foundation and venture-backed company developing next-generation vaccines on the MIMIX sustained-release microneedle platform. MIMIX combines high temperature stability, ease of administration, and enhanced immunogenicity through “infection mimicry” to create more effective vaccines that are easily delivered around the world. Prior to founding Vaxess, Michael spent time at Google, Toyota, and Honda R&D where he helped bring a wide range of products to market and earned fifteen patents for innovative new designs. Michael received his B.S. in Mechanical Engineering from Purdue University and his M.B.A. from Harvard Business School.